Viewing Study NCT04253561


Ignite Creation Date: 2025-12-24 @ 12:07 PM
Ignite Modification Date: 2026-03-02 @ 5:52 PM
Study NCT ID: NCT04253561
Status: UNKNOWN
Last Update Posted: 2023-04-18
First Post: 2020-01-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer Patients
Sponsor: SOLTI Breast Cancer Research Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module